ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Joint replacement"

  • Abstract Number: 1154 • 2018 ACR/ARHP Annual Meeting

    Patterns of Opioid Use and Patient Characteristics before Total Hip and Knee Replacement

    Yinzhu Jin1, Daniel Solomon1,2, Patricia D. Franklin3, Yvonne C. Lee4, Joyce Lii1, Jeffrey N. Katz5 and Seoyoung C. Kim6,7, 1Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Musculoskeletal Center of Excellence, University of Massachusetts Medical School, Worcester, MA, 4Northwestern University Feinberg School of Medicine, Chicago, IL, 5Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 6Division of Pharmacoepidemiology and Pharmocoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 7Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Patients with moderate-to-severe hip or knee arthritis often use opioids before undergoing total joint replacement (TJR). Preoperative opioid use may lead to persistent opioid…
  • Abstract Number: 1178 • 2018 ACR/ARHP Annual Meeting

    Patients’ and Healthcare Professionals’ Resource Preferences for a Knowledge Translation Toolkit for Hip and Knee Replacement Rehabilitation

    Marie Westby1, Cheryl L. Koehn2, Sheila Kerr3 and Alison Hoens4, 1Centre for Hip Health and Mobility, Vancouver, BC, Canada, 2Arthritis Consumer Experts, Vancouver, BC, Canada, 3Patient Advisor, Vancouver, BC, Canada, 4Physical Therapy, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Widely varying rehabilitation practices for total joint replacement (TJR) for hip and knee osteoarthritis (OA) contribute to inconsistent patient outcomes and satisfaction. Informed by…
  • Abstract Number: 1238 • 2018 ACR/ARHP Annual Meeting

    The Effect of Antibiotic Therapy on Positive Culture Results Among Patients with Prosthetic Joint Septic Arthritis

    Efrat Gur Rosset1, Mary Louise Fowler2, Sarah Lieber3, Robert Shmerling4 and Ziv Paz3,5,6, 1Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel, 2Boston University School of Medicine, Boston, MA, 3Beth Israel Deaconess Medical Center, Boston, MA, 4Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, 5Galilee Medical Center, Nahariya, Israel, 6Azrieli Faculty of Medicine, Bar-Ilan University, Sefad, Israel

    Background/Purpose: Little is known about the effects of antibiotic therapy on synovial and blood culture results among patients with prosthetic joint septic arthritis (PJSA). In…
  • Abstract Number: 1239 • 2018 ACR/ARHP Annual Meeting

    Organisms Associated with Prosthetic Joint Septic Arthritis over the Past Two Decades: Data from a Single Tertiary Medical Center Located in the Northeastern United States

    Manny Menachem Arieli1, Mary Louise Fowler2, Sarah Lieber3, Robert Shmerling4, Mohammad Naffaa5 and Ziv Paz1,3, 1Azrieli Faculty of Medicine, Bar-Ilan University, Sefad, Israel, 2Boston University School of Medicine, Boston, MA, 3Beth Israel Deaconess Medical Center, Boston, MA, 4Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, 5Galilee Medical Center, Israel, Naharriya, Israel

    Background/Purpose: In recent years, joint replacement surgery (JRS) has become increasingly common. Prosthetic joint septic arthritis (PJSA) may complicate JRS in up to 1% of…
  • Abstract Number: 1373 • 2018 ACR/ARHP Annual Meeting

    Predictive Probabilities Are Superior in Communicating the Clinical Relevance of Cartilage Thickness As an Imaging Biomarker of Knee Osteoarthritis Progression

    C. Kent Kwoh1,2, Erin L. Ashbeck1, Edward J. Bedrick3 and Felix Eckstein4,5, 1University of Arizona Arthritis Center, Tucson, AZ, 2Division of Rheumatology, Department of Medicine, The University of Arizona, Tucson, AZ, 3Department of Epidemiology and Biostatistics, University of Arizona, Tucson, AZ, 4Institute of Anatomy, Paracelsus Medical University, Salzburg, Austria, 5Chondrometrics GmbH, Ainring, Germany

    Background/Purpose: Establishing a threshold of clinically important cartilage loss is of great interest for the design and interpretation of knee OA trials of structure-modifying treatments.…
  • Abstract Number: 445 • 2018 ACR/ARHP Annual Meeting

    Interleukin-1β Inhibition with Canakinumab Associates with Reduced Rates of Total Hip and Knee Replacement (THR/TKR) and Osteoarthritis (OA) Symptoms: Exploratory Results from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

    Matthias Schieker1, Linda Mindeholm1, Jens Praestgaard2, Celeste Scotti1, Daniel Solomon3, Tom Thuren4, Kasper Dreyer5, Ronenn Roubenoff1 and Paul M. Ridker6, 1Novartis Institutes for Biomedical Research, Basel, Switzerland, 2Novartis Institutes for Biomedical Research, East Hanover, NJ, 3Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 4Novartis Pharma AG, East Hanover, NJ, 5Novartis Pharma AG, Basel, Switzerland, 6Division of Preventive Medicine, Cardiovascular Diseases, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: In osteoarthritis (OA), there are no therapeutics to prevent disease progression. Canakinumab, a monoclonal antibody targeting interleukin-1β, reduced inflammation and cardiovascular events in the…
  • Abstract Number: 953 • 2018 ACR/ARHP Annual Meeting

    Evaluating MRI-Detected Knee Inflammation Prior to Total Knee Replacement As a Predictive Biomarker of Clinically Important Pain Reduction Two Years Later

    Manjinder Kaur1, Lili Zhou2, Erin L. Ashbeck2, Ernest Vina3, Frank Roemer4, Ali Guermazi5, David J. Hunter6 and C. Kent Kwoh1,2, 1Division of Rheumatology, Department of Medicine, The University of Arizona, Tucson, AZ, 2University of Arizona Arthritis Center, Tucson, AZ, 3University of Arizona School of Medicine, University of Arizona Arthritis Center, Tucson, AZ, 4Department of Radiology, Boston University School of Medicine, Boston, MA, USA, Boston, MA, 5Boston University School of Medicine, Boston, MA, 6University of Sydney, Sydney, Australia

    Background/Purpose: Some patients do not experience clinical improvement after total knee replacement (TKR). Presence of structural abnormalities on MRI before surgery may inform pain prognosis…
  • Abstract Number: 2188 • 2016 ACR/ARHP Annual Meeting

    Association Between Extent of Symptomatic Joint Involvement in Osteoarthritis and Comorbid Lung Disease in Patients Scheduled for Joint-Replacement Surgery

    Anthony V. Perruccio1,2,3, Rajiv Gandhi4, J. Denise Power5,6 and Elizabeth M. Badley7, 1The Arthritis Program, University Health Network, Toronto, ON, Canada, 2Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 3Health Care & Outcomes Research, Krembil Research Institute, University Health Network, Toronto, ON, Canada, 4University Health Network, Arthritis Program, Toronto, ON, Canada, 5Arthritis Program, Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 6Dalla Lana School of Public Health, Toronto, ON, Canada, 7Toronto Western Research Institute, Toronto, ON, Canada

    Background/Purpose: Comorbidity is highly prevalent in osteoarthritis (OA), although the origin of this is not well understood. The presence of multi-joint symptoms in OA, and…
  • Abstract Number: 2303 • 2016 ACR/ARHP Annual Meeting

    Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada from 2000-2011

    Sharan K. Rai1,2, J. Antonio Avina-Zubieta2,3, Natalie McCormick2,4, Mary A. De Vera2,5, Diane Lacaille2,6, Eric C. Sayre2 and Hyon K. Choi7,8, 1Experimental Medicine, University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada, 3Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 4Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 5Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 6Medicine, University of British Columbia, Vancouver, BC, Canada, 7Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 8Arthritis Research Canada, Vancouver, BC, Canada

    Background/Purpose: Gout and rheumatoid arthritis (RA) are the two most common forms of inflammatory arthritis worldwide. As hospitalizations for both conditions lead to substantial health…
  • Abstract Number: 2592 • 2016 ACR/ARHP Annual Meeting

    The Impact of Biologic Therapy Introduction on Hip and Knee Replacement Among Rheumatoid Arthritis Patients: An Interrupted Time Series Analysis Using the Clinical Practice Research Datalink

    Samuel Hawley1, René Cordtz2, Lene Dreyer3, Christopher J. Edwards4, Nigel K Arden5, Antonella Delmestri5, Cyrus Cooper1,6, Andrew Judge5 and Daniel Prieto-Alhambra7, 1Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, 2Dept. of Rheumatology/C, Copenhagen University Hospital Gentofte, Hellerup, Denmark, 3Internal Medicine - Rheumatology Section, Copenhagen University Hospital at Gentofte, Copenhagen, Denmark, 4University of Southampton, Southampton, United Kingdom, 5Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, 6Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom, 7Internal Medicine and Primary Care, URFOA-IMIM, Parc de Salut Mar; Idiap Jordi Gol i Gurina-Institut Català de la Salut; Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK, Barcelona, Spain

    Background/Purpose: In several developed countries it has been observed that the incidence of orthopaedic surgery among rheumatoid arthritis (RA) patients has been in decline, despite…
  • Abstract Number: 2312 • 2015 ACR/ARHP Annual Meeting

    Patient Preferences for Total Knee Replacement Surgery:  Two Year Follow-up  

    Ernest Vina1, Di Ran2, Erin Ashbeck2, Said Ibrahim3, Michael J. Hannon4, Jin Zhou5 and C. Kent Kwoh1, 1Rheumatology, University of Arizona, Tucson, AZ, 2Arthritis Center, University of Arizona, Tucson, AZ, 3Medicine, University of Pennsylvania, Philadelphia, PA, 4Medicine, University of Pittsburgh, Pittsburgh, PA, 5Epidemiology & Biostatistics, University of Arizona, Tucson, AZ

    Background/Purpose: Patients’ preferences for total knee replacement (TKR) may determine actual receipt of TKR and may also change over time.  Yet, no study has longitudinally…
  • Abstract Number: 2968 • 2014 ACR/ARHP Annual Meeting

    Improvement Following Total Knee Replacement (TKR) Surgery:  Exploring Preoperative Symptoms and Change in Preoperative Symptoms

    Ernest R. Vina1, Michael J. Hannon2 and C. Kent Kwoh3, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh and VA Healthcare System, Pittsburgh, PA, 2Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 3Division of Rheumatology and Clinical Immunology, University of Arizona, Tucson, AZ

    Background/Purpose Few have examined the trajectories of preoperative health-related quality of life (HRQL) measures in osteoarthritis (OA) patients who undergo TKR.  Yet, the type and…
  • Abstract Number: 1841 • 2014 ACR/ARHP Annual Meeting

    Eventual Joint Failure and Surgery Rates in Rheumatoid Arthritis Remain High in Patients with Moderate Disease Activity in the First 5 Years of Disease

    Elena Nikiphorou1, Lewis Carpenter2, Sam Norton3, Josh Dixey4, Patrick Kiely5, David Walsh6,7 and Adam Young1,8, 1School of Life & Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom, 2Centre for Lifespan & Chronic Illness Research, University of Hertfordshire, Hatfield, United Kingdom, 3Institute of Psychiatry, King's College London, London, United Kingdom, 4Rheumatology, New Cross Hospital, Wolverhampton, United Kingdom, 5Rheumatology Dept, St. Georges Healthcare NHS Trust, London, United Kingdom, 6Arthritis Research UK Pain Centre, University of Nottingham, Nottingham, United Kingdom, 7Rheumatology, Sherwood Forest Hospitals NHS Foundation Trust, Sutton-in-Ashfield, United Kingdom, 8Rheumatology, ERAS, St Albans City Hospital, St Albans, United Kingdom

    Background/Purpose: It is well-established that sustained high disease activity in RA results in worse outcomes. In reality many patients remain in low/moderate disease activity states,…
  • Abstract Number: 413 • 2014 ACR/ARHP Annual Meeting

    Association of Antinuclear Antibodies with Lung Disease, Malignancy and Joint Replacement in Rheumatoid Arthritis

    Reshmi Raveendran1, Bobby Kwanghoon Han2, Quan-Zhen Li3 and Nancy J. Olsen1, 1Medicine, Penn State MS Hershey Medical Center, Hershey, PA, 2Rheumatology, Cooper Medical School of Rowan University, Camden, NJ, 3Immunology, University of Texas Southwestern Medical Center, Dallas, TX

    Background/Purpose Antinuclear antibodies (ANAs) are present in a significant proportion of patients with rheumatoid arthritis (RA).  Positivity for ANA in RA has been associated with…
  • Abstract Number: 65 • 2014 ACR/ARHP Annual Meeting

    Impact of Dropout and Total Knee Replacement on Joint Space Narrowing Estimation: Data from Osteoarthritis Initiaive

    Jamie E. Collins and Elena Losina, Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA

    Impact of dropout and TKR on Joint Space Narrowing estimation: data from Osteoarthritis InitiativeBackground/Purpose: Structural progression in knee osteoarthritis (OA) is often measured by Joint…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology